Lichty BD - Search Results

1

Human coronavirus OC43 nucleocapsid protein binds microRNA 9 and potentiates NF-κB activation.

Lai FW, Stephenson KB, Mahony J, Lichty BD. Lai FW, et al. Among authors: lichty bd. J Virol. 2014 Jan;88(1):54-65. doi: 10.1128/JVI.02678-13. Epub 2013 Oct 9. J Virol. 2014. PMID: 24109243 Free PMC article.

2

Induction of innate immunity against herpes simplex virus type 2 infection via local delivery of Toll-like receptor ligands correlates with beta interferon production.

Gill N, Deacon PM, Lichty B, Mossman KL, Ashkar AA. Gill N, et al. J Virol. 2006 Oct;80(20):9943-50. doi: 10.1128/JVI.01036-06. J Virol. 2006. PMID: 17005672 Free PMC article.

3

Using G-deleted vesicular stomatitis virus to probe the innate anti-viral response.

Lai F, Kazdhan N, Lichty BD. Lai F, et al. Among authors: lichty bd. J Virol Methods. 2008 Nov;153(2):276-9. doi: 10.1016/j.jviromet.2008.07.001. Epub 2008 Aug 23. J Virol Methods. 2008. PMID: 18692525

4

The p14 FAST protein of reptilian reovirus increases vesicular stomatitis virus neuropathogenesis.

Brown CW, Stephenson KB, Hanson S, Kucharczyk M, Duncan R, Bell JC, Lichty BD. Brown CW, et al. Among authors: lichty bd. J Virol. 2009 Jan;83(2):552-61. doi: 10.1128/JVI.01921-08. Epub 2008 Oct 29. J Virol. 2009. PMID: 18971262 Free PMC article.

5

Recombinant vesicular stomatitis virus transduction of dendritic cells enhances their ability to prime innate and adaptive antitumor immunity.

Boudreau JE, Bridle BW, Stephenson KB, Jenkins KM, Brunellière J, Bramson JL, Lichty BD, Wan Y. Boudreau JE, et al. Among authors: lichty bd. Mol Ther. 2009 Aug;17(8):1465-72. doi: 10.1038/mt.2009.95. Epub 2009 Apr 28. Mol Ther. 2009. PMID: 19401673 Free PMC article.

6

Vesicular stomatitis virus as a novel cancer vaccine vector to prime antitumor immunity amenable to rapid boosting with adenovirus.

Bridle BW, Boudreau JE, Lichty BD, Brunellière J, Stephenson K, Koshy S, Bramson JL, Wan Y. Bridle BW, et al. Among authors: lichty bd. Mol Ther. 2009 Oct;17(10):1814-21. doi: 10.1038/mt.2009.154. Epub 2009 Jul 14. Mol Ther. 2009. PMID: 19603003 Free PMC article.

7

A high-throughput pharmacoviral approach identifies novel oncolytic virus sensitizers.

Diallo JS, Le Boeuf F, Lai F, Cox J, Vaha-Koskela M, Abdelbary H, MacTavish H, Waite K, Falls T, Wang J, Brown R, Blanchard JE, Brown ED, Kirn DH, Hiscott J, Atkins H, Lichty BD, Bell JC. Diallo JS, et al. Among authors: lichty bd. Mol Ther. 2010 Jun;18(6):1123-9. doi: 10.1038/mt.2010.67. Epub 2010 Apr 13. Mol Ther. 2010. PMID: 20389287 Free PMC article.

8

Potentiating cancer immunotherapy using an oncolytic virus.

Bridle BW, Stephenson KB, Boudreau JE, Koshy S, Kazdhan N, Pullenayegum E, Brunellière J, Bramson JL, Lichty BD, Wan Y. Bridle BW, et al. Among authors: lichty bd. Mol Ther. 2010 Aug;18(8):1430-9. doi: 10.1038/mt.2010.98. Epub 2010 Jun 15. Mol Ther. 2010. PMID: 20551919 Free PMC article.

9

Adaptive antiviral immunity is a determinant of the therapeutic success of oncolytic virotherapy.

Sobol PT, Boudreau JE, Stephenson K, Wan Y, Lichty BD, Mossman KL. Sobol PT, et al. Among authors: lichty bd. Mol Ther. 2011 Feb;19(2):335-44. doi: 10.1038/mt.2010.264. Epub 2010 Nov 30. Mol Ther. 2011. PMID: 21119618 Free PMC article.

10

IL-15 and type I interferon are required for activation of tumoricidal NK cells by virus-infected dendritic cells.

Boudreau JE, Stephenson KB, Wang F, Ashkar AA, Mossman KL, Lenz LL, Rosenthal KL, Bramson JL, Lichty BD, Wan Y. Boudreau JE, et al. Among authors: lichty bd. Cancer Res. 2011 Apr 1;71(7):2497-506. doi: 10.1158/0008-5472.CAN-10-3025. Epub 2011 Feb 9. Cancer Res. 2011. PMID: 21307131

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

96 results

Search Page